11/23/2015 - 3:26pm

CVS Health has opted to only offer one of the two new PCSK9 inhibitors on its CVS/caremark commercial formularies. 

11/23/2015 - 2:57pm

The new indication provides another option for the estimated 300,000 patients who will undergo hip replacements in a year. 

11/23/2015 - 1:30pm

Perrigo is buying a Crohn’s disease treatment from AstraZeneca. 

11/23/2015 - 10:32am

A 15-member board composed will govern the combined company and Pfizer CEO Ian Read will be CEO of the combined company and Allergan CEO Brent Saunders will be the president and COO. 

11/20/2015 - 4:03pm

In preparation for this launch, Mission has expanded its sales force and increased promotional efforts to reach more primary care and internal medicine healthcare providers.

11/20/2015 - 3:55pm

Specialty medications represent only 1% of all prescriptions but, in 2014, these medications resulted in over 31% of all drug spending.

11/20/2015 - 12:10pm

Alchemia’s shareholders approved the sale of Fondaparinux at the company’s annual general meeting held on Nov. 10.

11/20/2015 - 10:31am

Mylan's acquisition of Jai Pharma brings Mylan a broad women's care portfolio, strong technical capabilities and dedicated hormone manufacturing. 

11/20/2015 - 9:50am

With the U.S. Treasury announcing plans to crack down on tax-inversion deals on Thursday, pharmaceutical giants Pfizer and Allergen have accelerated their merger talks, according to reports. The potential $150 billion deal could see Pfizer redomicile in Ireland. (Reuters)